Ethos Technologies Inc. Class A Common Stock
$ 11.84
3.50%
25 Feb - close price
- Market Cap 718,560,000 USD
- Current Price $ 11.84
- High / Low $ 12.20 / 11.44
- Stock P/E 12.71
- Book Value -2.96
- EPS 0.90
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA N/A %
- ROE N/A %
- 52 Week High 19.00
- 52 Week Low 9.45
About
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company is headquartered in San Diego, California.
Analyst Target Price
$19.75
Quarterly Earnings
| Mar 2024 | Dec 2023 | Sep 2023 | Dec 2022 | Jun 2022 | Mar 2022 | Sep 2021 | Mar 2021 | Sep 2020 | Mar 2020 | Dec 2019 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2024-05-29 | 2024-03-15 | 2023-10-03 | 2023-03-03 | 2022-07-21 | 2022-04-12 | 2021-10-12 | 2021-05-14 | 2020-10-30 | 2020-06-26 | 2020-03-04 | 2019-11-05 |
| Reported EPS | -0.23 | -0.23 | -0.2 | -0.26 | -0.44 | -0.44 | -0.42 | -0.64 | -0.68 | -0.69 | -1.54 | -1.47 |
| Estimated EPS | -0.24 | -0.25 | -0.22 | -0.48 | -0.38 | -0.33 | -0.57 | -0.49 | -0.74 | -0.73 | -1.59 | -1.73 |
| Surprise | 0.01 | 0.02 | 0.02 | 0.22 | -0.06 | -0.11 | 0.15 | -0.15 | 0.06 | 0.04 | 0.05 | 0.26 |
| Surprise Percentage | 4.1667% | 8% | 9.0909% | 45.8333% | -15.7895% | -33.3333% | 26.3158% | -30.6122% | 8.1081% | 5.4795% | 3.1447% | 15.0289% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LIFE
2026-02-23 11:05:46
J.P. Morgan analyst Pablo Singzon initiated a Buy rating for Ethos Technologies Inc. (LIFE) with a $13 price target, citing its tech-enabled life insurance model and consistent growth through direct-to-consumer and agency distribution. He expects strong double-digit growth, especially driven by the agency segment, despite recognizing a weaker financial profile and working-capital headwinds. Goldman Sachs also initiated coverage with a Buy rating and a $33.00 price target on the stock.
2026-01-30 16:45:07
Ethos, a digital life insurance platform, has filed for an IPO on the Nasdaq Global Select Market under the ticker "LIFE," with shares priced at $19.00. The company operates a digital platform connecting consumers, agents, and carriers, digitizing the insurance value chain and earning commissions without taking insurance risk. Ethos reported expected FY2025 revenue of $385–$387 million, significant year-over-year growth, and strong gross profit margins, aiming to address the substantial life insurance coverage gap.
2026-01-30 16:45:07
This article states that Ethos Technologies' shares opened at their IPO price, coinciding with a period of increased risk appetite in the markets. The full content of the article was not provided, but it likely discusses the company's market debut and the broader financial environment influencing investor behavior.
2026-01-30 01:27:00
Ethos Technologies Inc. (NASDAQ: LIFE) recently completed an initial public offering of 10.53 million Class A shares priced at $19 per share. The San Francisco-based insurance platform offered 5.13 million shares, while existing shareholders sold 5.4 million shares. Trading on the Nasdaq Global Select Market commenced on January 29, with Goldman Sachs & Co. LLC and J.P. Morgan acting as lead underwriters.
2026-01-29 09:51:00
Ethos (LIFE), a life insurance technology platform, priced its IPO at $19 per share, which was the middle of the expected range of $18-$20 per share. The company offered 5.13 million shares of class A stock in its initial public offering.
2026-01-21 16:45:07
Ethos Technologies Inc. has filed for an IPO to list its Class A common stock on the Nasdaq Global Select Market under the ticker symbol LIFE, with an expected price range of $18.00 to $20.00 per share. The company operates a digital life insurance platform, serving consumers, agents, and carriers, and stands out for already achieving GAAP profitability with strong revenue growth and margins. While offering exposure to a high-growth insurtech company, investors should consider risks such as concentrated voting power, regulatory challenges, and increasing competition.
